- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031003
Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants (9055A1-2000)
March 10, 2026 updated by: Société des Produits Nestlé (SPN)
Effect of an Infant Formula With High 2-Palmitic Vegetable Oil or an Identical Formula Supplemented With Oligofructose on Stool Composition and Stool Characteristics in Healthy Term Infants in Taiwan
- The primary objective of the study was to compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) of infants randomized to receive either standard formula, or 1 of 2 innovative formulas containing a new fat blend or the new fat blend plus fiber.
- The secondary objectives were to evaluate among the feeding groups, stool characteristics (stool consistency and frequency), GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ), and urinary markers (F2-isoprostanes and 8-hydroxy-2'-deoxyguanosine [8-OHdG], and urine osmolality and specific gravity).
- The primary safety objective was to describe the frequency of adverse events (AEs) among the formula-fed (FF) groups.
- The secondary safety objective was to describe anthropometric measures (weight, length, and head circumference) among the feeding groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hsinchu, Taiwan
- Mackay Memorial Hospital - Hsinchu Branch
-
Taipei, Taiwan
- Mackay Memorial Hospital
-
Taipei, Taiwan
- Chang Gung Medical Foundation, Taipei Branch
-
-
Tao-Yuan County
-
Linkou District, Tao-Yuan County, Taiwan
- Chang Gung Medical Foundation - Linkou Branch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 weeks to 1 month (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants; between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age ≥3rd and ≤97th percentiles according to Taiwan growth charts at the time of study entry.
- Human milk fed infants were exclusively consuming and tolerating HM and the mother must have made the decision to continue to exclusively breastfeed.
- Formula-fed infants were exclusively consuming and tolerating a cow's milk infant formula and parents/LAR must have previously made the decision to continue to exclusively formula feed.
Exclusion Criteria:
- Infants receiving any amount of supplemental HM with infant formula feeding or vice versa
- Family history of siblings with documented cow's milk protein intolerance/allergy
- Major congenital malformations, suspected or documented systemic or congenital infections, evidence systemic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control
Standard infant formula
|
Infant formula
|
|
Experimental: Experimental 1
Standard infant formula containing a new fat blend
|
Infant formula
|
|
Experimental: Experimental 2
Standard infant formula containing a new fat blend and fiber
|
Infant formula
|
|
No Intervention: Human Milk (HM)
Non-randomized Human Milk group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stool Composition
Time Frame: Day 28
|
Stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents
|
Day 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stool Consistency determined using a 3-day stool diary
Time Frame: Days 14 and 28
|
Stool consistency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits.
Average stool consistency scores are recorded on a validated 5-point scale (1 = Watery, 2 = Runny, 3 = Mushy Soft, 4 = Formed, 5 = Hard).
|
Days 14 and 28
|
|
Stool frequency determined using a 3-day stool diary
Time Frame: Day 14 and 28
|
Stool frequency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits.
The average number of stools per day is determined for each consecutive 3-day period.
|
Day 14 and 28
|
|
GI Tolerance
Time Frame: Baseline, Day 14 and Day 28
|
GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ)
|
Baseline, Day 14 and Day 28
|
|
Incidence of adverse events
Time Frame: From ICF signing until 14 days after last study feeding
|
From ICF signing until 14 days after last study feeding
|
|
|
Urine osmolality
Time Frame: Baseline and Day 28
|
Measure of hydration status
|
Baseline and Day 28
|
|
Urine pH
Time Frame: Baseline and Day 28
|
Measure of hydration status
|
Baseline and Day 28
|
|
Anthropometric measurements
Time Frame: Baseline, Day 14 and Day 28
|
The anthropometry measurements will be determined by feeding group and by study visit.
|
Baseline, Day 14 and Day 28
|
|
Anthropometric measurements (z-scores)
Time Frame: Baseline, Day 14 and Day 28
|
The z-scores will be determined by feeding group and by study visit.
|
Baseline, Day 14 and Day 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
December 23, 2013
First Submitted That Met QC Criteria
January 7, 2014
First Posted (Estimated)
January 9, 2014
Study Record Updates
Last Update Posted (Actual)
March 13, 2026
Last Update Submitted That Met QC Criteria
March 10, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B3611001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bottle Feeding
-
Centre Hospitalier Intercommunal CreteilCompletedFeeding Behavior | Feeding, BottleFrance
-
California Polytechnic State University-San Luis...Completed
-
Drexel UniversityMonell Chemical Senses CenterCompleted
-
NestléCompletedBottle FeedingPhilippines
-
California Polytechnic State University-San Luis...Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedStress | Complications | Breastfeeding | Bottle Feeding | Family RelationshipUnited States
-
California Polytechnic State University-San Luis...CompletedBreastfeeding | Bottle Feeding | Mother-Infant InteractionUnited States
-
Wake Forest University Health SciencesCompleted
-
University of California, San FranciscoCompletedBreastfeeding | Breastfeeding, Exclusive | Feeding, Bottle | Morbidity;PerinatalUnited States
-
The Oregon ClinicCompletedFeeding, Bottle | Ankyloglossia | Feeding Disorder of Infancy and ChildhoodUnited States
Clinical Trials on Infant formula
-
Jovie USA, LLCIQVIA RDS Inc.; ObvioHealthCompleted
-
Société des Produits Nestlé (SPN)University College, LondonCompletedGrowth | Infant FormulaUnited Kingdom
-
Nara OrganicsPaidion Research, Inc.Completed
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Laboratorios OrdesaUnknownInfant DevelopmentSpain
-
Société des Produits Nestlé (SPN)Completed